News
- Author:
- Myles Starr
Publish date: March 16, 2023
A nationwide study found that pain medications approved to treat sickle cell disease were prescribed to fewer than one in three patients with SCD.<...
News
- Author:
- Myles Starr
Publish date: March 8, 2023
The state-level disparities highlight gaps in physicians’ understanding of how social factors contribute to disparities in TNBC risk.
News
- Author:
- Myles Starr
Publish date: February 22, 2023
“There’s no antiviral that you can take for Zika. Until we have a vaccine, the key to controlling/preventing Zika is controlling the mosquitoes tha...
News
- Author:
- Myles Starr
Publish date: February 10, 2023
Radiation therapy was 50% less likely to be prescribed for patients age 70 and older with early-stage breast cancer.
News
- Author:
- Myles Starr
Publish date: February 1, 2023
Interim results in the phase 3 ATLAS trial seemed to buttress the benefits of intensive maintenance therapies for multiple myeloma, post transplant...
News
- Author:
- Myles Starr
Publish date: December 20, 2022
Findings support the use of dolutegravir an raltegravir as part of WHO-recommended regimens for treating HIV.
News
- Author:
- Myles Starr
Publish date: December 16, 2022
Treatments meet unmet need and address unanswered questions.
News
- Author:
- Myles Starr
Publish date: December 15, 2022
A study on the impact of platinum therapy on long-term TNBC outcomes ranks among the most popular.
News
- Author:
- Myles Starr
Publish date: December 14, 2022
“It can be dosed monthly or every 2 months ... This could be a consideration for women who might have problems tolerating oral pills during pregnan...
News
- Author:
- Myles Starr
Publish date: December 13, 2022
Study found that embryo transfer based on the timing of ERT was no better than that based on the standard protocol.
News
- Author:
- Myles Starr
Publish date: November 23, 2022
On implementation of opt-out testing, the proportion of tests performed increased from 57.9% to 69% in a study.
